Recent molecular and clinical studies have shown that invasion may occur very early in
tumor development, thus emphasizing the potential importance of specific and sensitive …

Abstract Background Circulating tumor cells (CTCs) have long been considered a reflection
of tumor aggressiveness. Hematogenous spreading of CTCs from a primary tumor is a …

Circulating tumour cells (CTCs) have been considered for a long time in reflecting the
aggressiveness of tumours. As a result, many attempts have been made to develop assays …

The presence of circulating tumor cells (CTCs) in peripheral blood can serve as a “liquid
biopsy” approach and has thus emerged lately as one of the hottest fields in cancer …

Eight million people die of cancer each year and 90% of deaths are caused by systemic
disease. Circulating tumor cells (CTCs) contribute to the formation of metastases and thus …

Circulating tumour cells (CTCs) can be detected in the blood of many patients with different
types of early or advanced cancer using antibody-based assays or molecular methods. In …

The potential clinical utility of circulating tumor cells (CTCs) in the diagnosis and
management of cancer has drawn a lot of attention in the past 10 years. CTCs disseminate …

Solid cancers are a leading cause of death worldwide, primarily due to the failure of effective
clinical detection and treatment of metastatic disease in distant sites. There is growing …

Abstract Detection of Circulating Tumor Cells (CTCs) in peripheral blood can serve as a
“liquid biopsy” approach and as a source of valuable tumor markers. CTCs are rare, and …

Recent advances in technology now permit robust and reproducible detection of circulating
tumour cells (CTCs) from a simple blood test. Standardization in methodology has been …